Shanghai Hongchao, a shareholder of Shenlian Biotech (688098.SH), and its co-actors reduced their holdings of the company by 1.5% by a total of 1.5%

Zhitong Finance · Aug 2, 2023 04:51

Zhitong Financial APP News, Shenlian Biological (688098.SH) issued an announcement that on August 2, 2023, the company received a "letter on the progress of the implementation of the share reduction plan" issued by the shareholder Shanghai Hongchao and its concerted actor Shanghai Fenghong. From May 24 to August 2, 2023, Shanghai Hongchao and its concerted actor Shanghai Fenghong reduced their holdings by a total of 6.1549 million shares, accounting for 1.5% of the company's total share capital. The number of the reduction plan has been more than half, and the reduction plan has not yet been completed.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

申联生物(688098.SH)股东上海泓潮及其一致行动人累计减持公司1.5%股份

Shanghai Hongchao, a shareholder of Shenlian Biotech (688098.SH), and its co-actors reduced their holdings of the company by 1.5% by a total of 1.5%

Risk Disclaimer

Statement